In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical response than intravitreal injection the other, a new study shows. Medscape Medical News
Category: News
Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business …
National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision,” “we,” “our,” “us” or the “Company”) today reported its financial results for the second quarter ended June 28, 2025. “Our strong performance this quarter ref…
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that the Company will participate in…
FDA Approves of VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
FDA Approves VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase I…
GLP-1 RAs May Up Optic Neuropathy Risk in Seniors With Diabetes
Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes, a study of Medicare enrollees shows. Medscape Medical News
iCare World USA Appoints Dawna Owens as Director of Strategic Partnerships
RALEIGH, N. C.–(BUSINESS WIRE)– #Ophthalmology–Dawna Owens joins iCare USA as Director of Strategic Partnerships, strengthening alliances across healthcare and enterprise sectors.
Glaukos Announces Second Quarter 2025 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Stanton Optical Launches Advanced Eye Health Services Across 35 U.S. Locations
DELRAY BEACH, Fla.–(BUSINESS WIRE)–Stanton Optical, a leading retail brand under Now Optics and a national leader in affordable, full-service eye care, is expanding on-site clinical services to 35 locations nationwide in partnership with Physicians E…
National Vision Releases Annual Sustainability Report Highlighting 2024 Progress
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2024 Sustainability Report, “A World Worth Seeing.” The report focuses on the company’s performance across its Social, Employees,…
GLP-1 Users May Face Optic Nerve Damage Risk in First Year
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity. Medscape Medical News
National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and…
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 stu…
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
CAMBRIDGE, England–(BUSINESS WIRE)–Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lea…
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland–(BUSINESS WIRE)–betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of te…